Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma. (scientific article published on 13 September 2017)

Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies

Q28079232

TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition

Q28512991

Fibroblast growth factor signalling: from development to cancer

Q29616827

Improved survival with MEK inhibition in BRAF-mutated melanoma

Q29620663

Oesophageal carcinoma

Q34325751

CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression

Q34627193

hypoxia-inducible factors activate CD133 promoter through ETS family transcription factors.

Q34805209

Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease

Q35020888

Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance

Q35816889

Outcomes from a prospective trial of endoscopic radiofrequency ablation of early squamous cell neoplasia of the esophagus

Q36419431

Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell Population

Q36471425

Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation

Q36734197

Enhanced Expression of Fibroblast Growth Factor Receptor 3 IIIc Promotes Human Esophageal Carcinoma Cell Proliferation

Q36737108

FGFR1 promotes the stem cell-like phenotype of FGFR1-amplified non-small cell lung cancer cells through the Hedgehog pathway

Q37046814

The tumor microenvironment and its contribution to tumor evolution toward metastasis

Q37318832

IGFBP3 promotes esophageal cancer growth by suppressing oxidative stress in hypoxic tumor microenvironment

Q37516299

The cancer stem cell: premises, promises and challenges

Q37851011

Cancer stem cells: current status and evolving complexities

Q38019174

The role of radiotherapy in the multimodal management of esophageal cancer

Q38116720

Prediction of response to radiotherapy in the treatment of esophageal cancer using stem cell markers

Q38396653

Cancer stem cells in oesophageal squamous cell carcinoma: Identification, prognostic and treatment perspectives

Q38443189

NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulates the survival and migration of tumor-associated macrophages and cancer cells.

Q38763653

Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma

Q38812372

Endothelial cells induce cancer stem cell features in differentiated glioblastoma cells via bFGF.

Q38843112

EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition

Q38883950

A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors.

Q38905550

Mitochondrial SOD2 regulates epithelial-mesenchymal transition and cell populations defined by differential CD44 expression

Q38912201

AKT/GSK-3β regulates stability and transcription of snail which is crucial for bFGF-induced epithelial-mesenchymal transition of prostate cancer cells

Q38969060

Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras.

Q40213134

Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene.

Q40353020

Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors

Q41376475

Notch receptor inhibition reveals the importance of cyclin D1 and Wnt signaling in invasive esophageal squamous cell carcinoma.

Q42028034

Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor-suppressor activities.

Q42040176

Endoscopic submucosal dissection of early esophageal cancer.

Q51404433

Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper

Q74662163

Tyrosine kinases as targets for cancer therapy

Q80367757

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

esophageal squamous cell carcinoma

Q108442577

P304

page(s)

1073-1083

P577

publication date

2017-10-01

P1433

published in

Carcinogenesis

Q326022

P1476

title

Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma

P478

volume

Reverse relations

cites work (P2860)

Q96817058	CDK5RAP3 as tumour suppressor negatively regulates self-renewal and invasion and is regulated by ERK1/2 signalling in human gastric cancer
Q98906651	FGF/FGFR signaling in health and disease
Q64951868	FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5p.
Q88955678	FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer
Q91596559	Function of fibroblast growth factor 2 in gastric cancer occurrence and prognosis
Q93143116	Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics
Q93078789	Long Pentraxin-3 Follows and Modulates Bladder Cancer Progression
Q64083249	Metformin Regulates the Expression of CD133 Through the AMPK-CEBPβ Pathway in Hepatocellular Carcinoma Cell Lines
Q93252546	New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer
Q91695602	Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties
Q64054193	Targeting p21-activated kinase 1 inhibits growth and metastasis via Raf1/MEK1/ERK signaling in esophageal squamous cell carcinoma cells
Q93021945	The Role of Fgf Signaling on Epithelial Cell Differentiation in Mouse Vagina
Q89746470	The paradox of cancer genes in non-malignant conditions: implications for precision medicine
Q90028633	p300 Acetyltransferase Is a Cytoplasm-to-Nucleus Shuttle for SMAD2/3 and TAZ Nuclear Transport in Transforming Growth Factor β-Stimulated Hepatic Stellate Cells